M. Ashby

发表

Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.

N. Ueno, R. Champlin, L. Miller, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer

C. Verschraegen, A. Kudelka, H. Broxmeyer, 2000, Annals of Internal Medicine.

Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.

J. Berlin, A. Grothey, F. Kabbinavar, 2009, The oncologist.

A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.

J. Vose, A. Nademanee, J. Fay, 1998, Blood.

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.

P. Kuna, T. Jakob, D. Ledford, 2013, The Journal of allergy and clinical immunology.

Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.

J. Fay, Dennie V. Jones, J. Lynch, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recombinant human thrombopoietin clinical development

Dennie V. Jones, G. Somlo, G. Fyfe, 1998, Stem cells.

Symptom Control and Improved Functioning: The Effect of Omalizumab on Asthma-Related Quality of Life (ARQL)

M. Kosinski, B. Bresnahan, A. Luskin, 2005, The Journal of asthma : official journal of the Association for the Care of Asthma.

Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study

P. Mease, E. Olech, W. Rigby, 2013, The Journal of Rheumatology.

Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study

J. Lynch, M. Benyunes, R. Herzig, 2001, Bone Marrow Transplantation.

Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.

Lesley J. Murray, R. Hoffman, R. Cohen, 1998, Experimental hematology.

Changing results of HLA-identical sibling bone marrow transplantation in patients with haematological malignancy during the period 1981-1990.

J. Biggs, K. Atkinson, A. Dodds, 1993, Australian and New Zealand journal of medicine.

Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.

J. Biggs, K. Atkinson, A. Dodds, 1987, Bone marrow transplantation.

Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients.

D. Golovsky, J. Biggs, K. Atkinson, 1991, Bone Marrow Transplantation.

Cardiac dysfunction in the trastuzumab clinical trials experience.

C. Hudis, S. Shak, M. Murphy, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.

J. Vose, A. Nademanee, J. Dipersio, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.

A. Grothey, F. Kabbinavar, P. Flynn, 2012, European journal of cancer.

High incidence of early leukemic relapse in patients given cyclosporin and T cell depleted HLA-identical sibling marrow transplants for acute leukemia in first remission.

J. Biggs, K. Atkinson, A. Dodds, 1988, Australian and New Zealand journal of medicine.

A comparative study of T-cell depleted and non-depleted marrow transplantation for hematological malignancy.

J. Biggs, K. Atkinson, A. Dodds, 1987, Australian and New Zealand journal of medicine.

The impact of leukemia status at the time of HLA-identical sibling marrow transplantation on subsequent complication rate and survival of adults with acute leukemia.

J. Biggs, K. Atkinson, A. Dodds, 1986, Australian and New Zealand journal of medicine.

A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.

J. Biggs, K. Atkinson, A. Dodds, 1991, Australian and New Zealand journal of medicine.

A prospective randomised trial of cyclosporin versus methotrexate after HLA-identical sibling marrow transplantation for patients with acute leukemia in first remission: analysis 2.5 years after last patient entry.

J. Biggs, K. Atkinson, A. Dodds, 1988, Australian and New Zealand journal of medicine.

TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.

M. Blaney, N. Gabrail, E. Sandler, 2010, Journal of vascular and interventional radiology : JVIR.

Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.

T. Casale, J. Corren, Y. Deniz, 2003, The Journal of allergy and clinical immunology.

Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy.

S. Vuk-Pavlović, Y. Yen, J. Doroshow, 1999, Blood.

CD4+ T cells appear capable of initiating graft-versus-host disease across non-major histocompatibility complex (MHC) barriers in man.

K. Atkinson, J. Biggs, M. Ashby, 1987, Bone marrow transplantation.

A phase III, open-label, single-arm study of tenecteplase for restoration of function in dysfunctional central venous catheters.

M. Blaney, R. Shulman, B. Jacobs, 2011, Journal of vascular and interventional radiology : JVIR.

Exploring racial differences in outcome for metastatic colorectal cancer: Results from a large prospective observational cohort study (BRiTE).

B. Polite, M. Kozloff, A. Sing, 2010 .

Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study

J. Berlin, A. Grothey, F. Kabbinavar, 2010, Oncology.

Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection

S. Deeks, J. Eron, M. Conant, 1996, The Lancet.

Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study

P. Mease, E. Olech, W. Rigby, 2013, Journal of Rheumatology.